In the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Mohammed Issa, vice president of commercial at US Janssen Neuroscience.
They chat about the current state of mental healthcare and how innovation in pharma is rising to meet the challenges and opportunities created by the COVID-19 pandemic. They also touch on patient centricity, innovation in pharma, recent technological developments, and the importance of making health equity a priority, not just passively but proactively.
Tune in for an interesting and wide-ranging discussion of this dynamic therapeutic area and how one pharma company is tackling it.
You can listen to episode 51 of the pharmaphorum podcast in the player below, download the episode to your computer or find it – and subscribe to the rest of the series in iTunes, Spotify, acast, Stitcher and Podbean.
